• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆同型半胱氨酸浓度与传统心血管危险因素对新发外周动脉疾病风险的联合影响

Joint Effects of Plasma Homocysteine Concentration and Traditional Cardiovascular Risk Factors on the Risk of New-Onset Peripheral Arterial Disease.

作者信息

Liu Mengyuan, Fan Fangfang, Liu Bo, Jia Jia, Jiang Yimeng, Sun Pengfei, He Danmei, Liu Jiahui, Li Yuxi, Huo Yong, Li Jianping, Zhang Yan

机构信息

Department of Cardiology, Peking University First Hospital, Beijing, People's Republic of China.

Institute of Cardiovascular Disease, Peking University First Hospital, Beijing, People's Republic of China.

出版信息

Diabetes Metab Syndr Obes. 2020 Sep 28;13:3383-3393. doi: 10.2147/DMSO.S267122. eCollection 2020.

DOI:10.2147/DMSO.S267122
PMID:33061499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7532045/
Abstract

PURPOSE

Hyperhomocysteinemia is an independent risk factor for cardio- and cerebrovascular diseases. However, the relationship between plasma homocysteine (Hcy) concentration and peripheral arterial disease (PAD) has not been completely characterized. The aim of the present study was to determine the relationship between plasma Hcy concentration and new-onset PAD and to assess the effects of combinations of Hcy and traditional cardiovascular risk factors.

PATIENTS AND METHODS

We conducted a prospective community-based cohort study of 3119 Chinese participants who did not have PAD at baseline, with a median follow-up period of 2.30 years. We used multivariate logistic regression models to evaluate the relationship between high Hcy (≥10µmol/L) and new-onset PAD. The effects of combinations of high Hcy and traditional cardiovascular risk factors were assessed using logistic regression analysis.

RESULTS

After adjustment for 14 covariates, high Hcy concentration was significantly associated with new-onset PAD (odds ratio [OR]=2.08, 95% confidence interval [CI]: 1.08-4.03, =0.030). Smokers with high Hcy concentration were substantially more likely to have new-onset PAD than non-smokers with normal Hcy concentration (OR=4.44, 95% CI: 1.77-11.12, =0.001). The effect of diabetes on PAD became significant when present in combination with high Hcy concentration (OR=3.67, 95% CI: 1.25-10.80, =0.018). Participants with both elevated Hcy levels and older age had the highest risk of new-onset PAD (OR=4.28, 95% CI: 1.83-10.01, <0.001). With regard to the joint effect of Hcy and hypertension, dyslipidemia or sex, there was also a trend towards increased risk across four different groups ( for trend=0.026, 0.035, 0.016, respectively).

CONCLUSION

High plasma Hcy concentration independently predicts the incidence of PAD. Furthermore, there is a joint effect of high Hcy concentration and traditional cardiovascular risk factors such as smoking, diabetes and aging on the incidence of PAD.

摘要

目的

高同型半胱氨酸血症是心脑血管疾病的独立危险因素。然而,血浆同型半胱氨酸(Hcy)浓度与外周动脉疾病(PAD)之间的关系尚未完全明确。本研究旨在确定血浆Hcy浓度与新发PAD之间的关系,并评估Hcy与传统心血管危险因素联合作用的影响。

患者与方法

我们对3119名基线时无PAD的中国参与者进行了一项基于社区的前瞻性队列研究,中位随访期为2.30年。我们使用多变量逻辑回归模型评估高Hcy(≥10µmol/L)与新发PAD之间的关系。使用逻辑回归分析评估高Hcy与传统心血管危险因素联合作用的影响。

结果

在对14个协变量进行调整后,高Hcy浓度与新发PAD显著相关(比值比[OR]=2.08,95%置信区间[CI]:1.08 - 4.03,P = 0.030)。高Hcy浓度的吸烟者比Hcy浓度正常的非吸烟者发生新发PAD的可能性显著更高(OR = 4.44,95% CI:1.77 - 11.12,P = 0.001)。糖尿病与高Hcy浓度同时存在时对PAD的影响变得显著(OR = 3.67,95% CI:1.25 - 10.80,P = 0.018)。Hcy水平升高且年龄较大的参与者发生新发PAD的风险最高(OR = 4.28,95% CI:1.83 - 10.01,P < 0.001)。关于Hcy与高血压、血脂异常或性别之间的联合作用,在四个不同组中也存在风险增加的趋势(趋势P值分别为0.026、0.035、0.016)。

结论

高血浆Hcy浓度可独立预测PAD的发生率。此外,高Hcy浓度与吸烟、糖尿病和衰老等传统心血管危险因素对PAD的发生率存在联合作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1458/7532045/9160833befca/DMSO-13-3383-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1458/7532045/9160833befca/DMSO-13-3383-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1458/7532045/9160833befca/DMSO-13-3383-g0001.jpg

相似文献

1
Joint Effects of Plasma Homocysteine Concentration and Traditional Cardiovascular Risk Factors on the Risk of New-Onset Peripheral Arterial Disease.血浆同型半胱氨酸浓度与传统心血管危险因素对新发外周动脉疾病风险的联合影响
Diabetes Metab Syndr Obes. 2020 Sep 28;13:3383-3393. doi: 10.2147/DMSO.S267122. eCollection 2020.
2
Association of plasma homocysteine with peripheral arterial disease in the hypertensive adults: A cross-sectional study.血浆同型半胱氨酸与高血压成年人外周动脉疾病的关系:一项横断面研究。
J Clin Hypertens (Greenwich). 2024 Mar;26(3):286-294. doi: 10.1111/jch.14766. Epub 2024 Feb 20.
3
Fifteen-year clinical prognosis and cardiovascular or limb event associated with homocysteine levels in peripheral arterial disease.外周动脉疾病中同型半胱氨酸水平相关的15年临床预后及心血管或肢体事件
J Cardiol. 2023 Nov;82(5):423-428. doi: 10.1016/j.jjcc.2023.04.021. Epub 2023 May 3.
4
Screening of plasma homocysteine in peripheral arterial disease.外周动脉疾病患者血浆同型半胱氨酸的筛查
Ann Med. 2001 Feb;33(1):48-54. doi: 10.3109/07853890109002059.
5
WBC count predicts the risk of new-onset peripheral arterial disease in a Chinese community-based population.白细胞计数可预测中国社区人群新发外周动脉疾病的风险。
Hypertens Res. 2017 Nov;40(11):932-936. doi: 10.1038/hr.2017.64. Epub 2017 May 11.
6
Association of Serum Homocysteine With Peripheral Arterial Disease in Patients Without Diabetes: A Study Based on National Health and Nutrition Examination Survey Database.血清同型半胱氨酸与无糖尿病患者外周动脉疾病的关系:基于国家健康和营养调查数据库的研究。
Am J Cardiol. 2024 May 1;218:16-23. doi: 10.1016/j.amjcard.2024.03.002. Epub 2024 Mar 6.
7
[Characteristics of hyperhomocysteinemia in dialysis patients].[透析患者高同型半胱氨酸血症的特征]
Acta Med Croatica. 2006;60(1):21-6.
8
Relationship between serum homocysteine, fibrinogen, lipoprotein-a level, and peripheral arterial disease: a dose-response meta-analysis.血清同型半胱氨酸、纤维蛋白原、脂蛋白(a)水平与外周动脉疾病的关系:剂量反应荟萃分析。
Eur J Med Res. 2022 Nov 21;27(1):261. doi: 10.1186/s40001-022-00870-1.
9
Homocysteine and peripheral arterial disease: systematic review and meta-analysis.同型半胱氨酸与外周动脉疾病:系统评价与荟萃分析
Eur J Vasc Endovasc Surg. 2009 Sep;38(3):316-22. doi: 10.1016/j.ejvs.2009.05.007. Epub 2009 Jun 27.
10
Elevated Homocysteine Levels Are Associated With the Metabolic Syndrome and Cardiovascular Events in Hypertensive Patients.同型半胱氨酸水平升高与高血压患者的代谢综合征及心血管事件相关。
Am J Hypertens. 2015 Jul;28(7):943-50. doi: 10.1093/ajh/hpu248. Epub 2014 Dec 12.

引用本文的文献

1
Role of hyperhomocysteinemia in atherosclerosis: from bench to bedside.高同型半胱氨酸血症在动脉粥样硬化中的作用:从实验台到临床
Ann Med. 2025 Dec;57(1):2457527. doi: 10.1080/07853890.2025.2457527. Epub 2025 Feb 3.
2
Association between serum folate levels and migraine or severe headaches: A nationwide cross-sectional study.血清叶酸水平与偏头痛或严重头痛的关联:一项全国性横断面研究。
Medicine (Baltimore). 2024 Nov 8;103(45):e40458. doi: 10.1097/MD.0000000000040458.
3
Intermediate-Term Prognostic Value of Homocysteine in Acute Coronary Syndrome Complicated with or without Hypertension: A Multicenter Observational Cohort Study.

本文引用的文献

1
Peripheral Arterial Disease in Women: The Gender Effect.女性外周动脉疾病:性别效应。
Cardiovasc Revasc Med. 2020 Mar;21(3):404-408. doi: 10.1016/j.carrev.2019.05.026. Epub 2019 May 31.
2
Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.2015 年全球、区域和国家外周动脉疾病的患病率和风险因素:更新的系统评价和分析。
Lancet Glob Health. 2019 Aug;7(8):e1020-e1030. doi: 10.1016/S2214-109X(19)30255-4.
3
Homocysteine and Hyperhomocysteinaemia.同型半胱氨酸和高同型半胱氨酸血症。
同型半胱氨酸在伴或不伴高血压的急性冠脉综合征中的中期预后价值:一项多中心观察性队列研究
Rev Cardiovasc Med. 2023 Jul 18;24(7):210. doi: 10.31083/j.rcm2407210. eCollection 2023 Jul.
4
Association of plasma homocysteine with peripheral arterial disease in the hypertensive adults: A cross-sectional study.血浆同型半胱氨酸与高血压成年人外周动脉疾病的关系:一项横断面研究。
J Clin Hypertens (Greenwich). 2024 Mar;26(3):286-294. doi: 10.1111/jch.14766. Epub 2024 Feb 20.
5
Association between geriatric nutritional risk index and depression prevalence in the elderly population in NHANES.老年营养风险指数与 NHANES 中老年人抑郁患病率的相关性研究。
BMC Public Health. 2024 Feb 14;24(1):469. doi: 10.1186/s12889-024-17925-z.
6
Additive effect between homocysteine and low-density-lipoprotein cholesterol upon incidence of novel carotid plaque formation: data from a Chinese community-based cohort.同型半胱氨酸与低密度脂蛋白胆固醇对新发颈动脉斑块形成的相加作用:来自中国社区队列的研究数据。
BMC Cardiovasc Disord. 2023 Jun 30;23(1):332. doi: 10.1186/s12872-023-03282-z.
7
Association of Blood Heavy Metal Exposure with Atherosclerotic Cardiovascular Disease (ASCVD) Among White Adults: Evidence from NHANES 1999-2018.血液重金属暴露与白人成年人动脉粥样硬化性心血管疾病(ASCVD)的关联:来自 NHANES 1999-2018 的证据。
Biol Trace Elem Res. 2023 Sep;201(9):4321-4333. doi: 10.1007/s12011-022-03537-4. Epub 2022 Dec 21.
8
Association between migraine and cardiovascular disease: A cross-sectional study.偏头痛与心血管疾病之间的关联:一项横断面研究。
Front Cardiovasc Med. 2022 Nov 24;9:1044465. doi: 10.3389/fcvm.2022.1044465. eCollection 2022.
9
Association between serum Klotho levels and the prevalence of diabetes among adults in the United States.血清 Klotho 水平与美国成年人糖尿病患病率之间的关系。
Front Endocrinol (Lausanne). 2022 Nov 9;13:1005553. doi: 10.3389/fendo.2022.1005553. eCollection 2022.
10
Relationship between serum homocysteine, fibrinogen, lipoprotein-a level, and peripheral arterial disease: a dose-response meta-analysis.血清同型半胱氨酸、纤维蛋白原、脂蛋白(a)水平与外周动脉疾病的关系:剂量反应荟萃分析。
Eur J Med Res. 2022 Nov 21;27(1):261. doi: 10.1186/s40001-022-00870-1.
Curr Med Chem. 2019;26(16):2948-2961. doi: 10.2174/0929867325666180313105949.
4
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).2017年欧洲心脏病学会(ESC)与欧洲血管外科学会(ESVS)合作制定的外周动脉疾病诊断和治疗指南:涵盖颅外颈动脉和椎动脉、肠系膜、肾、上肢和下肢动脉粥样硬化疾病的文件 认可机构:欧洲卒中组织(ESO) 欧洲心脏病学会(ESC)和欧洲血管外科学会(ESVS)外周动脉疾病诊断和治疗特别工作组
Eur Heart J. 2018 Mar 1;39(9):763-816. doi: 10.1093/eurheartj/ehx095.
5
Associations of plasma homocysteine levels with peripheral systolic blood pressure and noninvasive central systolic blood pressure in a community-based Chinese population.在一个基于社区的中国人群中,血浆同型半胱氨酸水平与外周收缩压和无创中心收缩压的相关性。
Sci Rep. 2017 Jul 24;7(1):6316. doi: 10.1038/s41598-017-06611-3.
6
Hyperhomocysteinaemia is an independent risk factor for peripheral arterial disease in a Chinese Han population.高同型半胱氨酸血症是中国汉族人群外周动脉疾病的独立危险因素。
Atherosclerosis. 2017 Aug;263:205-210. doi: 10.1016/j.atherosclerosis.2017.05.006. Epub 2017 May 5.
7
Pathophysiology of Intermittent Claudication in Peripheral Artery Disease.外周动脉疾病间歇性跛行的病理生理学
Circ J. 2017 Feb 24;81(3):281-289. doi: 10.1253/circj.CJ-16-1286. Epub 2017 Jan 26.
8
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2016 AHA/ACC 指南:下肢外周动脉疾病患者管理——美国心脏病学会/美国心脏协会实践指南工作组的报告。
Circulation. 2017 Mar 21;135(12):e726-e779. doi: 10.1161/CIR.0000000000000471. Epub 2016 Nov 13.
9
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年全球、区域和国家310种疾病和损伤的发病率、患病率及伤残调整生命年:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1545-1602. doi: 10.1016/S0140-6736(16)31678-6.
10
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.1980 - 2015年全球、区域和国家249种死因的预期寿命、全死因死亡率和死因别死亡率:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1459-1544. doi: 10.1016/S0140-6736(16)31012-1.